John Relakis

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

Stavros Niarchos Foundation(Current)

National School of Public Health

National Public Health Organization

John Relakis is an author at Stavros Niarchos Foundation specializing in pharmacoeconomic evaluation, cost-utility analysis, and cost-effectiveness modeling.

Publications per year

2015–2016

Publications

Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema

Georgia Kourlaba, John Relakis, R Mahon et al. · Cost Effectiveness and Resource Allocation · 2016 · 12 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study

Georgia Kourlaba, Vasiliki Rapti, A. Alexopoulos et al. · BMC Health Services Research · 2015 · 10 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

1–2 of 2